CARL CARLSMED INC

Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025

Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025

CARLSBAD, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its second quarter 2025 financial results after market close on Thursday, August 28, 2025. Management will also host a conference call and concurrent webcast starting at 1:30 PM Pacific Time.

Conference Call Information

To participate in this event, dial in approximately 5 to 10 minutes before the start of the conference call.

Event Date: Thursday, August 28, 2025

Time: 1:30 PM Pacific Time

Participant Registration:

A replay of the webcast will be available shortly after the conclusion of the call and will be archived on the company's website .

About Carlsmed

Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.

Investor Relations

Media

LeAnn Burton

Senior Director Brand Marketing



EN
14/08/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CARLSMED INC

 PRESS RELEASE

Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results 

Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results  Fourth quarter revenue of $15.2 million; 61% growth YoY  Full year revenue of $50.5 million; 86% growth YoY  CARLSBAD, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today reported financial results for the fourth quarter and full year ended December 31, 2025.  "We delivered another very strong quarter with 61% revenue growth year-over-year, gross margin expansion to 76.5%,...

 PRESS RELEASE

Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoske...

Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference CARLSBAD, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 2026 Canaccord Genuity Musculoskeletal Conference on March 2, 2026 at 11:30 AM CST in New Orleans, LA.   A live webcast will be available to registered participants. Following the presentation, the webcast replay will be available at About Carlsmed, Inc. Carlsmed is a medical technology company pioneering ...

 PRESS RELEASE

Carlsmed Announces first corra™ personalized Cervical Plating Procedur...

Carlsmed Announces first corra™ personalized Cervical Plating Procedure The corra™ Cervical Plating System marks the debut of Carlsmed's patient-specific fixation portfolio CARLSBAD, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the first personalized cervical plating procedure using the corra™ Cervical Plating System, the latest addition to its portfolio of personalized spine surgery solutions. The procedure, which was performed by Dr. Aaron Clark at the University of California San Francisco (UCSF), represents an...

 PRESS RELEASE

Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Re...

Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 CARLSBAD, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its fourth quarter and full year 2025 financial results after market close on Wednesday, February 25, 2026. Management will also host a conference call and concurrent webcast starting at 1:30 PM Pacific Time. Conference Call Information To participate in this event, dial in approximately 5 to...

 PRESS RELEASE

Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody...

Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure CARLSBAD, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the successful completion of the first posterior lumbar spine surgery using the Company’s aprevo® Lumbar Bi-lateral Posterior System. The procedure was performed by Orthopedic Spine Surgeon CJ Kleck, M.D. at the University of Colorado Hospital in Denver, Colorado. “This clinical milestone strengthens our position as a leader in personalized, data-driven spine solutions desig...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch